Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.Weigong Zhou, Robert T. Chen, Vitali Pool et al.|PubMed|2003Cited by 397
Understanding vaccine safety information from the Vaccine Adverse Event Reporting SystemFrederick Varricchio, Robert T. Chen, John Iskander et al.|The Pediatric Infectious Disease Journal|2004Cited by 379
Prevalence of Anti-Gelatin IgE Antibodies in People With Anaphylaxis After Measles-Mumps-Rubella Vaccine in the United StatesVitali Pool, M. Miles Braun, John M. Kelso et al.|PEDIATRICS|2002Cited by 136
Neurologic disease associated with 17D-204 yellow fever vaccination: A report of 15 casesAnn McMahon, Martín S. Cetron, Rachel B. Eidex et al.|Vaccine|2006Cited by 132
Adverse event reports following vaccination for Lyme disease: December 1998–July 2000Sarah Lathrop, Edward B. Hayes, Robert Ball et al.|Vaccine|2002Cited by 93